Geneseeq
PrivateLast Round
Growth Equity
Jan 5, 2020
Est. Valuation
$904M
Total Funding Raised
$307.52M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Geneseeq operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Growth Equity round in January 2020.
Geneseeq is a precision oncology company that provides genomic profiling technology to accelerate precision cancer care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical Devices, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneseeq Comparables
Compare Geneseeq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genecast | 89% | |
| Annoroad Gene Technology | 87% | |
| New Genetron Holding Limited | 87% |
For institutional investors. Book with your work email.
Geneseeq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jan 5, 2020 | ||||
| Series D | Dec 26, 2019 | ||||
| Series C | Nov 23, 2017 | ||||
| Series C | Jul 20, 2017 | ||||
| Series B Extension | Feb 1, 2017 | ||||
Series B | Jun 12, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Geneseeq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dinova Capital | Series B Extension |
| China Reform Holdings Corporation Ltd. | Series D |
| China Resources Pharmaceutical Industry Investment Fund | Growth Equity |
| Huatai Zijin Investment | Series C |
| Xingzheng Innovation Capital | Series C |
| 兴证创新资本管理有限公司 | Series C |
| E Fund Management | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 17% QoQ from 35 to 41 employees.
- Aug 10, 2026
Open roles increased to 127, 363% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 11, 2026
Geneseeq Technology Inc. and Roche have an earlier collaboration for ROZLYTREK (entrectinib), building on PanTRKare(TM)'s NMPA-approved companion diagnostic applications.
For institutional investors. Book with your work email.
Geneseeq Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Geneseeq's valuation, stock price, and market status.
Is Geneseeq a public or private company?
Geneseeq is a private company.
What is the current stock price of Geneseeq?
Geneseeq is a private company, so its shares have no public market price. Caplight tracks Geneseeq's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Geneseeq worth (valuation)?
Geneseeq's valuation is estimated at $904.0M based on funding round data.
Can I buy Geneseeq stock?
Geneseeq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Geneseeq's last funding round?
Geneseeq's most recent funding round was Growth Equity on January 5, 2020.
Who are the main investors in Geneseeq?
Key investors in Geneseeq include China Reform Holdings Corporation Ltd., China Resources Pharmaceutical Industry Investment Fund, Xingzheng Innovation Capital, DNV Capital.
Will Geneseeq IPO soon?
No public IPO plans have been announced for Geneseeq.
How can I track Geneseeq secondary market activity?
Caplight tracks bids, offers, and trades in Geneseeq's shares on secondary markets.